Galapagos N.V. (GLPG) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2022)
GLPG's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
By Geography
GLPG Revenue Analysis (2014–2025)
As of March 1, 2026, Galapagos N.V. (GLPG) generated trailing twelve-month (TTM) revenue of $1.11 billion, reflecting explosive growth of +1093.2% year-over-year. The most recent quarter (Q4 2025) recorded $900.8 million in revenue, up 1165.8% sequentially.
Looking at the longer-term picture, GLPG's 5-year compound annual growth rate (CAGR) stands at +18.4%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $1.11 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows GLPG's business is primarily driven by Upfront payments and milestone payments (67%), and Jyseleca (33%). With over half of revenue concentrated in Upfront payments and milestone payments, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ARGX (+335.2% YoY), CANF (-16.0% YoY), and ABVX (+125.1% YoY), GLPG has outperformed the peer group in terms of revenue growth. Compare GLPG vs ARGX →
Peer Comparison
Compare GLPG's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GLPGCurrent | $1.1B | +1093.2% | +18.4% | 40.6% | |
| ARGX | $2.2B | +335.2% | +94.6% | -1.0% | |
| CANF | $674,000 | -16.0% | -19.8% | -1206.2% | |
| ABVX | $11M | +125.1% | +457.7% | -1602.9% | |
| KYMR | $39M | -16.7% | +2.9% | -891.3% | |
| TGTX | $329M | +31.0% | +364.6% | 12.7% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.11B | +303.5% | $623.1M | 56.0% | $451.1M | 40.6% |
| 2024 | $275.6M | +15.0% | $240.8M | 87.4% | $-188,338,000 | -68.3% |
| 2023 | $239.7M | -0.6% | $239.7M | 100.0% | $-88,263,000 | -36.8% |
| 2022 | $241.2M | -50.2% | $241.2M | 100.0% | $-131,056,000 | -54.3% |
| 2021 | $484.8M | +1.4% | $483.2M | 99.7% | $-165,597,000 | -34.2% |
| 2020 | $478.1M | -42.7% | $-45,614,000 | -9.5% | $-178,632,000 | -37.4% |
| 2019 | $834.9M | +189.1% | $414.8M | 49.7% | $368.7M | 44.2% |
| 2018 | $288.8M | +127.3% | $-34,040,000 | -11.8% | $-44,807,000 | -15.5% |
| 2017 | $127.1M | -1.9% | $-91,415,000 | -71.9% | $-89,802,000 | -70.7% |
| 2016 | $129.5M | +227.4% | $-10,057,000 | -7.8% | $-11,491,000 | -8.9% |
See GLPG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GLPG Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare GLPG vs AGIO
See how GLPG stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is GLPG's revenue growth accelerating or slowing?
GLPG revenue is accelerating at +1093.2% year-over-year, exceeding the 5-year CAGR of +18.4%. TTM revenue reached $1.1B. Growth momentum has increased versus prior periods.
What is GLPG's long-term revenue growth rate?
Galapagos N.V.'s 5-year revenue CAGR of +18.4% reflects the sustained expansion pattern. Current YoY growth of +1093.2% is above this long-term average.
How is GLPG's revenue distributed by segment?
GLPG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.